T45.622 Poisoning by hemostatic drug, intentional self-harm

Name of the Condition

• Poisoning by hemostatic drug, intentional self-harm (ICD-10 code: T45.622)

Summary

This condition involves intentional self-harm resulting from the ingestion or exposure to hemostatic drugs, which are medications used to control bleeding. It includes toxic effects or adverse reactions due to deliberate overdose or misuse of these agents, which work by promoting clot formation or inhibiting clot breakdown.

Causes

Intentional self-harm may occur from deliberate ingestion of hemostatic drugs in excess, often as a means of self-harm. This can result from intentional overdose, misuse, or intentional exposure to these agents. Underlying factors may involve psychological distress, suicidal ideation, or intent to cause harm.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety, or suicidal ideation).
• Access to hemostatic medications (e.g., at home or in healthcare settings).
• Prior episodes of self-harm or substance misuse.
• Social or environmental stressors contributing to intentional harm.
• Lack of supervision or restricted access to medications in vulnerable populations.

Symptoms

• Excessive clotting (e.g., deep vein thrombosis, pulmonary embolism) or paradoxical bleeding.
• Gastrointestinal or intracranial hemorrhage.
• Signs of systemic toxicity (e.g., dizziness, confusion, hypotension).
• Allergic reactions or anaphylaxis.
• Nausea, vomiting, or abdominal pain.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, patient history (including intent), and laboratory tests to assess drug levels or coagulation status. Imaging may be used to detect complications like thrombosis or bleeding. Documentation of intentional self-harm is critical for accurate coding.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms (e.g., anticoagulants for excessive clotting or transfusions for bleeding), and addressing psychological needs. Supportive care, such as monitoring vital signs and organ function, is essential. Psychiatric evaluation and intervention are often required.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timely intervention, and underlying mental health status. Follow-up includes monitoring for complications, reassessment of coagulation parameters, and ongoing psychiatric care to address self-harm risk.

Complications

• Severe bleeding or thrombotic events (e.g., stroke, organ damage).
• Organ dysfunction (e.g., kidney or liver failure).
• Long-term psychological effects or recurrence of self-harm.
• Adverse drug reactions or allergic responses.

Lifestyle & Prevention

• Secure storage of medications to limit access.
• Education on safe medication use and disposal.
• Mental health support and crisis intervention resources.
• Regular follow-up for individuals with self-harm history.

When to Seek Professional Help

Seek immediate medical attention if intentional self-harm with hemostatic drugs is suspected or confirmed. Signs of severe toxicity (e.g., uncontrolled bleeding, difficulty breathing, or loss of consciousness) require urgent care.

Tips for Medical Coders

Document the intent (intentional self-harm) clearly in the medical record, as this distinguishes T45.622 from other poisoning codes. Include details about the drug involved, timing of exposure, and clinical findings to support accurate coding. Ensure alignment with ICD-10-CM guidelines for self-harm and poisoning.